Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines
CADTH
Record ID 32014000855
English
Authors' recommendations:
One evidence-based guideline was identified for the use of naloxone to reverse the effects of narcotics in long-term care and palliative care patients. No evidence was identified regarding the clinical effectiveness and safety of naloxone to reverse the effects of narcotics in long-term care and palliative care patients.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/dec-2013/RA0654%20Naloxone%20in%20LTC%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Palliative Care
- Naloxone
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.